dokumendiregister.ee
Sissetulev dokumentAvalik

Kiri

Terviseamet · 17. detsember 2024
Viit
11.2-1/24/12870-1
Registreeritud
17. detsember 2024
Dokumendi liik
Sissetulev dokument
Adressaat
IQVIA MedTech
Saabumis/saatmisviis
e-post
Funktsioon
11.2 SULETUD 2025 Turustamise eelne järelevalve (pre-marketing surveillance)
Sari
11.2-1 Meditsiiniseadmete kliiniliste uuringute ja toimivusuuringute dokumendid (taotlused, load, muud teavitused ja kirjavahetus)
Toimik
11.2-1/2024
Vastutaja
Merili Saar-Abroi (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond)

Failid

Sisu (failidest)

Saatja: Podolak, Amira <[email protected]> Saaja: Meditsiiniseadmed (Medical Devices), Farinha, Ana Teema: Change of competent authority for medical devices studies Dear Sirs, I would like to ask if there is any break planned for the Christmas period. If we apply before Christmas, is it likely that we will receive validation comments by the end of this year? In addition, I would like to make sure how the evaluation of applications will look like due to the change in the authority for medical device testing? Will applications submitted in December still be evaluated by the Health Board, or will they be transferred to the State Agency of Medicines with the new year? I would also like to ask if we do not manage to submit the application in December and have to submit it to the State Agency of Medicines in January, does the fee we have already submitted remain valid? Would we have to start some kind of procedure to redirect the funds or refund and make the payment again to the new competent authority? I would highly appreciate your feedback on these matters. Kind regards, Amira Podolak, Ph.D. Associate Regulatory & Start-Up Manager IQVIA MedTech, Clinical Operations [cid:[email protected]] Learn more<http://www.iqviamedtech.com/> about IQVIA MedTech Home Based (Gdynia, Poland) tel. +48 22 430 31 34 Upcoming ooo: 23-24Dec (holidays), 25-26Dec (BH), 27-31Dec (holidays), 01Jan (BH) ________________________________________ IMPORTANT - PLEASE READ: This electronic message, including its attachments, is CONFIDENTIAL and may contain PROPRIETARY or LEGALLY PRIVILEGED or PROTECTED information and is intended for the authorized recipient of the sender. If you are not the intended recipient, you are hereby notified that any use, disclosure, copying, or distribution of this message or any of the information included in it is unauthorized and strictly prohibited. If you have received this message in error, please immediately notify the sender by reply e-mail and permanently delete this message and its attachments, along with any copies thereof, from all locations received (e.g., computer, mobile device, etc.). To the extent permitted by law, we may monitor electronic communications for the purposes of ensuring compliance with our legal and regulatory obligations and internal policies. We may also collect email traffic headers for analyzing patterns of network traffic and managing client relationships. For further information see our privacy-policy<https://www.iqvia.com/about-us/privacy/privacy-policy>. Thank you.
Allikas: Terviseamet dokumendiregister →